These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 33087136)

  • 1. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
    Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
    J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
    Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J
    Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Overexpression of ubiquitin-conjugating enzyme 2T induces radiotherapy resistance in hepatocellular carcinoma by enriching regulatory T cells in the tumor microenvironment].
    He X; Xiong S; Zhu Z; Sun J; Cao C; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jun; 44(6):1149-1158. PubMed ID: 38977345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
    Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
    Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression.
    Ho NPY; Leung CON; Wong TL; Lau EYT; Lei MML; Mok EHK; Leung HW; Tong M; Ng IOL; Yun JP; Ma S; Lee TKW
    Cell Death Dis; 2021 Feb; 12(2):148. PubMed ID: 33542213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.
    Sun Y; Wang J; Ma Y; Li J; Sun X; Zhao X; Shi X; Hu Y; Qu F; Zhang X
    J Exp Clin Cancer Res; 2021 Sep; 40(1):306. PubMed ID: 34587992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miR-34a-5p-c-MYC-CHK1/CHK2 Axis Counteracts Cancer Stem Cell-Like Properties and Enhances Radiosensitivity in Hepatocellular Cancer Through Repression of the DNA Damage Response.
    Zhao X; Zhuang Y; Wang B; Yuan B; Du S; Zeng Z
    Radiat Res; 2023 Jan; 199(1):48-60. PubMed ID: 36445955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
    Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway.
    Shen ZT; Chen Y; Huang GC; Zhu XX; Wang R; Chen LB
    BMC Cancer; 2019 Nov; 19(1):1075. PubMed ID: 31703572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
    Ren X; Li A; Ying E; Fang J; Li M; Yu J
    Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cucurbitacin B suppresses hepatocellular carcinoma progression through inducing DNA damage-dependent cell cycle arrest.
    Li QZ; Chen YY; Liu QP; Feng ZH; Zhang L; Zhang H
    Phytomedicine; 2024 Apr; 126():155177. PubMed ID: 38412667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0000291 contributes to hepatocellular carcinoma tumorigenesis by binding to miR-1322 to up-regulate UBE2T.
    Wang F; Zhong S; Mao C; Jin J; Wang H
    Ann Hepatol; 2022; 27(5):100722. PubMed ID: 35569812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of
    Shen L; Zhao K; Li H; Ning B; Wang W; Liu R; Zhang Y; Zhang A
    Epigenomics; 2019 Aug; 11(11):1283-1305. PubMed ID: 31355678
    [No Abstract]   [Full Text] [Related]  

  • 15. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
    Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
    Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma.
    Zhao X; Weng W; Jin M; Li S; Chen Q; Li B; Zhou Z; Lan C; Yang Y
    Med Sci Monit; 2021 Mar; 27():e929023. PubMed ID: 33658475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minichromosome maintenance 3 promotes hepatocellular carcinoma radioresistance by activating the NF-κB pathway.
    Yang Q; Xie B; Tang H; Meng W; Jia C; Zhang X; Zhang Y; Zhang J; Li H; Fu B
    J Exp Clin Cancer Res; 2019 Jun; 38(1):263. PubMed ID: 31208444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1.
    Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J
    Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation.
    Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
    Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma.
    Zhou ZQ; Zhao JJ; Chen CL; Liu Y; Zeng JX; Wu ZR; Tang Y; Zhu Q; Weng DS; Xia JC
    Mol Carcinog; 2019 Jan; 58(1):76-87. PubMed ID: 30182378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.